Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avantor Expands Global Production of Single­-Use Technologies | Contract Pharma

What are you searching for?

Sign in
Videos

Avantor Expands Global Production of Single­-Use Technologies

To increase single-use manufacturing footprint by 30% and double cleanroom space.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma



Avantor Inc. is increasing global capacity for single-use technologies used in the production of biologics and vaccines. In the U.S. and Europe, the company will increase its single-use manufacturing footprint by 30% and double its cleanroom space. The investment will support growing customer demand for monoclonal antibodies (mAbs), novel cell and gene therapies for oncology and other diseases, as well as vaccines, including those for COVID-19.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters